Dr. Thomas W. Donner, MD

Dr. Donner practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Donner's NPI, 1659329977, was assigned on May 5, 2006. Dr. Donner graduated from University of Virginia School of Medicine in 1986. Dr. Donner holds Maryland license D40059.

Dr. Donner's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Donner's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Donner is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Donner to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donner practices. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Donner's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Donner is licensed in Maryland.

CMS data shows 485 Medicare services from Dr. Donner across 6 procedure codes in 2024, for 276 Medicare patients. Medicare paid $32,914 for them.

CMS counts 276 Medicare patients who saw Dr. Donner in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have diabetes, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Donner's median patient age at 65, with 52% women.

In 2024, Dr. Donner wrote 2,592 Medicare Part D claims for 283 patients. 37% of them were for generic drugs. CMS names the drug for 2,279 of them, across 43 drugs with 11 or more claims each, at $1,463,915 in total drug cost. In 2023, CMS named 1,528 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Donner for performance year 2024, reported as part of a group. CMS lists Dr. Donner as offering telehealth.

Dmand AI links 24 papers to Dr. Donner, published from 2012 to 2024. 2012 was the busiest year, with 3. The most frequent topics are Diabetes Mellitus, Type 1, Hypoglycemic Agents and B-Lymphocytes. Dr. Donner has published most often in Front Immunol. Dr. Donner's most frequent co-authors are Richard G. Bach, MD, Robert L. Frye, MD and Eric B. Bass, MD.

CMS Open Payments shows 19 general payments to Dr. Donner from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 38% of the total. Novo Nordisk AS paid the most, $958.

Dr. Donner graduated from University of Virginia School of Medicine in 1986.